Deerfield Management Company, L.P. (Series C) Viatris Inc Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.04 Billion
- Q4 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Viatris Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 23,996,036 shares of VTRS stock, worth $265 Million. This represents 7.4% of its overall portfolio holdings.
Number of Shares
23,996,036
Previous 23,993,023
0.01%
Holding current value
$265 Million
Previous $279 Million
7.25%
% of portfolio
7.4%
Previous 5.18%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,133Shares Held
987MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.57 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.02 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$705 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$692 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$649 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...